Patents by Inventor Cyril LAVAUD

Cyril LAVAUD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE
    Publication number: 20240000832
    Abstract: The disclosure relates to the treatment and/or prevention of radiation damage by administering a reverse micelle system.
    Type: Application
    Filed: September 14, 2023
    Publication date: January 4, 2024
    Inventors: Elsa COMPTE, Patrick MAUREL, Sophie GRIVES-JERPHAGNON, Cyril LAVAUD, Lorraine BENIGNO-ANTON, Jean-Claude MAUREL
  • Treatment and prevention of injury due to radiation exposure
    Patent number: 11793831
    Abstract: The disclosure relates to the treatment and/or prevention of radiation damage by administering a reverse micelle system.
    Type: Grant
    Filed: July 5, 2019
    Date of Patent: October 24, 2023
    Assignee: MEDESIS PHARMA
    Inventors: Elsa Compte, Patrick Maurel, Sophie Grives-Jerphagnon, Cyril Lavaud, Lorraine Benigno-Anton, Jean-Claude Maurel
  • In situ preparation of cyano-bridged metal nanoparticles within a biocompatible reverse micellar system
    Patent number: 11278568
    Abstract: The present invention relates to a method for in situ preparation of cyano-bridged coordination polymers as metal nanoparticles within a biocompatible reverse micellar system by mixing at least two reverse micellar systems, each one containing at least one metal salt precursor. The invention also relates to the stabilization of theses nanoparticles by using a biocompatible reverse micellar system. This system takes part of the synthesis as a nanoreactor which comprises at least an acylglycerol, a sterol, lecithin, ethanol and water for the preparation of stable cyano-bridged metal nanoparticles without any use of additional stabilizer agent.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: March 22, 2022
    Assignees: MEDESIS PHARMA, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE MONTPELLIER
    Inventors: Jean-Claude Maurel, Elsa Compte, Cyril Lavaud, Yannick Guari, Joulia Guari, Jérôme Long
  • TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE
    Publication number: 20210315931
    Abstract: The disclosure relates to the treatment and/or prevention of radiation damage by administering a reverse micelle system.
    Type: Application
    Filed: July 5, 2019
    Publication date: October 14, 2021
    Inventors: Elsa COMPTE, Patrick MAUREL, Sophie GRIVES-JERPHAGNON, Cyril LAVAUD, Lorraine BENIGNO-ANTON, Jean-Claude MAUREL
  • IN SITU PREPARATION OF CYANO-BRIDGED METAL NANOPARTICLES WITHIN A BIOCOMPATIBLE REVERSE MICELLAR SYSTEM
    Publication number: 20180200295
    Abstract: The present invention relates to a method for in situ preparation of cyano-bridged coordination polymers as metal nanoparticles within a biocompatible reverse micellar system by mixing at least two reverse micellar systems, each one containing at least one metal salt precursor. The invention also relates to the stabilization of theses nanoparticles by using a biocompatible reverse micellar system. This system takes part of the synthesis as a nanoreactor which comprises at least an acylglycerol, a sterol, lecithin, ethanol and water for the preparation of stable cyano-bridged metal nanoparticles without any use of additional stabilizer agent.
    Type: Application
    Filed: July 8, 2016
    Publication date: July 19, 2018
    Inventors: Jean-Claude MAUREL, Elsa COMPTE, Cyril LAVAUD, Yannick GUARI, Joulia GUARI, Jérôme LONG